Top compounds associated with response to EML6


Feature Type Standardized
Nominal ANOVA
mRNA bid1870 gCSI pan-cancer AAC -0.18 0.002
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA pitstop2 CTRPv2 pan-cancer AAC 0.14 0.003
mRNA CIL41 CTRPv2 pan-cancer AAC 0.15 0.003
mRNA GW843682X CTRPv2 pan-cancer AAC 0.11 0.003
mRNA niclosamide CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Pazopanib GDSC1000 pan-cancer AAC -0.11 0.003
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC -0.14 0.004
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
Download CSV